Kathryn Nichol
Company: Pionarus Bio
Job title: Co-Founder and Chief
Seminars:
Panel Discussion: A Translational Journey: What Does it All Mean for Regulatory Approval? 3:30 pm
day: Day Two
Approval & Beyond: Risk Assessment in Selecting a Clinical Trial Outcome 2:00 pm
Review primary outcomes selected for existing examples of cannabinoid drug development: what worked, what didn’t, and why. Strengths and weaknesses in choosing patient-reported outcomes, clinician-reported outcomes, and objective outcomes. Agency guidance for specific therapeutic areas and agency partnershipRead more
day: Day Two